Histamine H1-Receptor Antagonistic Drug Olopatadine Suppresses TSLP in Atopic Dermatitis Model Mice

• Mayumi Higashi,
• Ikuroh Ohsawa,
• Fumino Oda,
• Yuko Yamada,
• Seiji Kawana,
• Kazumi Iida,
• Tsuyoshi Mitsuishi

Affiliations

Mayumi Higashi

Department of Dermatology, Tokyo Women's Medical University, Yachiyo Medical Center, Chiba

Ikuroh Ohsawa

Department of Environmental Gerontology, Tokyo Metropolitan Institute of Gerontology

Fumino Oda

Department of Dermatology, The Research Institute of Vaccine Therapy for Tumors and Infectious Diseases, Nippon Medical School, Tokyo, Japan

Yuko Yamada

Department of Dermatology, The Research Institute of Vaccine Therapy for Tumors and Infectious Diseases, Nippon Medical School, Tokyo, Japan

Seiji Kawana

Department of Dermatology, The Research Institute of Vaccine Therapy for Tumors and Infectious Diseases, Nippon Medical School, Tokyo, Japan

Kazumi Iida

The Research Institute of Vaccine Therapy for Tumors and Infectious Diseases, Nippon Medical School, Tokyo, Japan

Tsuyoshi Mitsuishi

Department of Dermatology, Tokyo Women's Medical University, Yachiyo Medical Center, Chiba